Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Market Report, "Auto Inflammatory Disease - Pipeline Review, H2 2013", published


Print article Print article
2013-12-22 00:07:12 - Fast Market Research recommends "Auto Inflammatory Disease - Pipeline Review, H2 2013" from Global Markets Direct, now available

Global Markets Direct's, 'Auto Inflammatory Disease - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Auto Inflammatory Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Auto Inflammatory Disease. Auto Inflammatory Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at
- www.fastmr.com/prod/755157_auto_inflammatory_disease_pipeline_re ..

Note*: Certain sections in the report may be removed or altered based

on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Auto Inflammatory Disease.
* A review of the Auto Inflammatory Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Auto Inflammatory Disease pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to Get this Report

* Identify and understand important and diverse types of therapeutics under development for Auto Inflammatory Disease.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Auto Inflammatory Disease pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned in this Report: Emergent BioSolutions Inc., Alba Therapeutics Corporation, Oncodesign SA

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Auto Inflammatory Disease Overview
Therapeutics Development
An Overview of Pipeline Products for Auto Inflammatory Disease
Auto Inflammatory Disease Therapeutics under Development by Companies
Auto Inflammatory Disease Therapeutics under Investigation by Universities/Institutes
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Auto Inflammatory Disease Therapeutics - Products under Development by Companies
Auto Inflammatory Disease Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Auto Inflammatory Disease Therapeutics Development
Emergent BioSolutions Inc.
Alba Therapeutics Corporation
Oncodesign SA
Auto Inflammatory Disease - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
AT-1004 Vaccine Adjuvants - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ES-301 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Permeability Inhibitor Candidates - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Permeability Inducer Candidates - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ES-62 Analogue - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SEL-212 Program - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AT-1006 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Receptor-interacting serine/threonine-protein kinase 2 Inhibitor - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Auto Inflammatory Disease Therapeutics - Drug Profile Updates
Auto Inflammatory Disease Therapeutics - Dormant Products
Auto Inflammatory Disease - Product Development Milestones
Featured News & Press Releases
Nov 11, 2012: Novartis' Phase II Data Show ACZ885 Delivered Rapid And Strong Symptom Relief While Reducing Frequency Of Attacks In Two Periodic Fever Syndromes
Sep 06, 2012: Generon Initiates Phase I Clinical Study For F-652 In Australia
Jun 06, 2012: Novartis Announces New Data From Two Trials Of ACZ885 At Annual Congress Of EULAR 2012
Jul 12, 2011: AnaptysBio Selects Anti-IL17 mAb Development Candidate To Treat Autoimmune And Inflammatory Conditions
Jun 23, 2011: Avila Presents Preclinical Data Of AVL-292 Demonstrating Suppression Of Autoimmune Disease Activity
May 13, 2008: ChemoCentryx Initiates Clinical Trial Of CCX354 For The Treatment Of Inflammatory Disease
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Auto Inflammatory Disease, H2 2013
Products under Development for Auto Inflammatory Disease - Comparative Analysis, H2 2013
Number of Products under Development by Companies, H2 2013
Number of Products under Investigation by Universities/Institutes, H2 2013
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2013

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=755157&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com